Health Care & Life Sciences » Biotechnology | Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Jiangxi Boya Bio-Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Jiangxi Boya Bio-Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
5,190,499
1.59%
1,826,997
1.17%
12/31/2017
E Fund Growth Enterprise Index ETF
793,556
0.24%
-127,900
0.59%
12/31/2017
772,025
0.24%
-249,000
0.54%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
568,500
0.17%
0
0%
07/31/2018
499,950
0.15%
499,950
0.35%
12/31/2017
466,850
0.14%
51,100
1%
12/31/2017
457,938
0.14%
-322,904
0.45%
12/31/2017
280,861
0.09%
-22,050
2.21%
12/31/2017
214,600
0.07%
214,600
0.3%
12/31/2017
Fullgoal Tiancheng Dividend Fund
158,200
0.05%
158,200
0.28%
12/31/2017

About Jiangxi Boya Bio-Pharmaceutical Co.

View Profile
Address
333 Huiquan Road
Fuzhou Jiangxi 344000
China
Employees -
Website http://www.china-boya.com
Updated 07/08/2019
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.